Inseego Corp. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the three and nine months ended September 30, 2026, disclosing a third-quarter net loss of $8,103 thousand and a year-to-date net loss of $21,077 thousand.
CION Investment Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting a net decrease in net assets from operations of $3,550 thousand for the third quarter.
SiTime Corporation filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter ended September 30, 2026, disclosing share count, risk factors, and financial results for the period.
Haemonetics Corporation filed its quarterly report on Form 10-Q for the fiscal quarter ended September 26, 2026, disclosing revenue, earnings, and balance sheet data for the three and six months ended on that date.
Eve Holding, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 5, 2026, disclosing a net loss of $161,094 thousand for the nine months ended September 30, 2026.
Yum China Holdings, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting third-quarter and year-to-date financial results for the company listed on NYSE:YUMC.
Citizens Financial Services, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 5, 2026, reporting third-quarter net income of $11.921 million and total assets of $3.413 billion.
Arhaus, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 5, 2026, disclosing third-quarter net revenue of $368.1 million and nine-month net revenue of $1.07 billion.
GigaCloud Technology Inc filed its Form 10-Q quarterly report for the period ended September 30, 2026, with the U.S. Securities and Exchange Commission on November 5, 2026, disclosing share counts, ownership structure, and operational definitions for its marketplace business.
BeOne Medicines Ltd. filed its Quarterly Report on Form 10-Q with the SEC for the quarterly period ended September 30, 2026, disclosing substantial revenue growth and a return to profitability across both the three- and nine-month periods.